APO Research
Talk to an analyst

APO RESEARCH · REPORT

Digital Therapeutics Platforms

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Digital Therapeutics Platforms Market Outlook and Growth Opportunities 2026

6 March 2026216 pages

Choose your research edition.

Industry ResearchDigital Therapeutics Platforms Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Digital Therapeutics Platforms Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Digital Therapeutics Platforms Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Digital Therapeutics Platforms Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Digital Therapeutics Platforms Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global Digital Therapeutics Platforms market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Digital Therapeutics Platforms is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Digital Therapeutics Platforms is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Digital Therapeutics Platforms is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Digital Therapeutics Platforms market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Digital Therapeutics Platforms market include Akili Interactive, DarioHealth, Teladoc Health, Voluntis, Sidekick Health, WellDoc, Talkspace, CogniFit and Tata Elxsi, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Digital Therapeutics Platforms market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Digital Therapeutics Platforms and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Digital Therapeutics Platforms revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Digital Therapeutics Platforms market.

Digital Therapeutics Platforms Segment by Company

Akili Interactive

DarioHealth

Teladoc Health

Voluntis

Sidekick Health

WellDoc

Talkspace

CogniFit

Tata Elxsi

Mahalo Health

2Morrow

Omada Health

Click Therapeutics

Orexo

ResMed

Virta Health

Bifourmis

SilverCloud (Amwell)

Noom

Big Health

Kaia Health

Cognoa

Headspace Health

CureApp

Calm Health

Riva Health

Sweetch-Health

Lark Health

Vida Health

Mahana Therapeutics

Blue Note Therapeutics

Lyra Health

Modern Health

Canary Health

Virgin Pulse

Slanhealth

Best Covered

Dami and Xiaomi

WeiMai

Jianhai Tech

Digital Therapeutics Platforms Segment by Type

Chronic Disease Digital Therapeutics

Psychiatric Disorders Digital Therapeutics

Quit Smoking Digital Therapeutics

Sleep Disorders and Respiratory Diseases Digital Therapeutics

Others

Digital Therapeutics Platforms Segment by Application

Enterprise

Personal

Digital Therapeutics Platforms Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Digital Therapeutics Platforms status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Digital Therapeutics Platforms key companies, revenue, market share, and recent developments.

3. To split the Digital Therapeutics Platforms breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Digital Therapeutics Platforms market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Digital Therapeutics Platforms significant trends, drivers, influence factors in global and regions.

6. To analyze Digital Therapeutics Platforms competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital Therapeutics Platforms market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Digital Therapeutics Platforms and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital Therapeutics Platforms.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Digital Therapeutics Platforms industry.

Chapter 3: Detailed analysis of Digital Therapeutics Platforms company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Digital Therapeutics Platforms in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Digital Therapeutics Platforms in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Digital Therapeutics Platforms Industry Trends Table 2. Digital Therapeutics Platforms Industry Drivers Table 3. Digital Therapeutics Platforms Industry Opportunities and Challenges Table 4. Digital Therapeutics Platforms Industry Restraints Table 5. Global Digital Therapeutics Platforms Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Digital Therapeutics Platforms Revenue Share by Company (2021-2026) Table 7. Global Digital Therapeutics Platforms Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Digital Therapeutics Platforms Key Company Manufacturing Base & Headquarters Table 9. Global Digital Therapeutics Platforms Company, Product Type & Application Table 10. Global Digital Therapeutics Platforms Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Digital Therapeutics Platforms by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Chronic Disease Digital Therapeutics Table 15. Significant Companies of Psychiatric Disorders Digital Therapeutics Table 16. Significant Companies of Quit Smoking Digital Therapeutics Table 17. Significant Companies of Sleep Disorders and Respiratory Diseases Digital Therapeutics Table 18. Significant Companies of Others Table 19. Global Digital Therapeutics Platforms Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Digital Therapeutics Platforms Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Digital Therapeutics Platforms Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Digital Therapeutics Platforms Sales Value Share by Type (2021-2026) Table 23. Global Digital Therapeutics Platforms Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Enterprise Table 25. Significant Companies of Personal Table 26. Global Digital Therapeutics Platforms Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Digital Therapeutics Platforms Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Digital Therapeutics Platforms Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Digital Therapeutics Platforms Sales Value Share by Application (2021-2026) Table 30. Global Digital Therapeutics Platforms Sales Value Share by Application (2027-2032) Table 31. Global Digital Therapeutics Platforms Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Digital Therapeutics Platforms Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Digital Therapeutics Platforms Sales Value Share by Region (2021-2026) Table 34. Global Digital Therapeutics Platforms Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Digital Therapeutics Platforms Sales Value Share by Region (2027-2032) Table 36. Global Digital Therapeutics Platforms Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Digital Therapeutics Platforms Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Digital Therapeutics Platforms Sales Value Market Share by Country (2021-2026) Table 39. Global Digital Therapeutics Platforms Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Digital Therapeutics Platforms Sales Value Market Share by Country (2027-2032) Table 41. Akili Interactive Company Information Table 42. Akili Interactive Business Overview Table 43. Akili Interactive Digital Therapeutics Platforms Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Akili Interactive Digital Therapeutics Platforms Product Portfolio Table 45. Akili Interactive Recent Development Table 46. DarioHealth Company Information Table 47. DarioHealth Business Overview Table 48. DarioHealth Digital Therapeutics Platforms Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. DarioHealth Digital Therapeutics Platforms Product Portfolio Table 50. DarioHealth Recent Development Table 51. Teladoc Health Company Information Table 52. Teladoc Health Business Overview Table 53. Teladoc Health Digital Therapeutics Platforms Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Teladoc Health Digital Therapeutics Platforms Product Portfolio Table 55. Teladoc Health Recent Development Table 56. Voluntis Company Information Table 57. Voluntis Business Overview Table 58. Voluntis Digital Therapeutics Platforms Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Voluntis Digital Therapeutics Platforms Product Portfolio Table 60. Voluntis Recent Development Table 61. Sidekick Health Company Information Table 62. Sidekick Health Business Overview Table 63. Sidekick Health Digital Therapeutics Platforms Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Sidekick Health Digital Therapeutics Platforms Product Portfolio Table 65. Sidekick Health Recent Development Table 66. WellDoc Company Information Table 67. WellDoc Business Overview Table 68. WellDoc Digital Therapeutics Platforms Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. WellDoc Digital Therapeutics Platforms Product Portfolio Table 70. WellDoc Recent Development Table 71. Talkspace Company Information Table 72. Talkspace Business Overview Table 73. Talkspace Digital Therapeutics Platforms Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Talkspace Digital Therapeutics Platforms Product Portfolio Table 75. Talkspace Recent Development Table 76. CogniFit Company Information Table 77. CogniFit Business Overview Table 78. CogniFit Digital Therapeutics Platforms Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. CogniFit Digital Therapeutics Platforms Product Portfolio Table 80. CogniFit Recent Development Table 81. Tata Elxsi Company Information Table 82. Tata Elxsi Business Overview Table 83. Tata Elxsi Digital Therapeutics Platforms Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Tata Elxsi Digital Therapeutics Platforms Product Portfolio Table 85. Tata Elxsi Recent Development Table 86. Mahalo Health Company Information Table 87. Mahalo Health Business Overview Table 88. Mahalo Health Digital Therapeutics Platforms Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Mahalo Health Digital Therapeutics Platforms Product Portfolio Table 90. Mahalo Health Recent Development Table 91. 2Morrow Company Information Table 92. 2Morrow Business Overview Table 93. 2Morrow Digital Therapeutics Platforms Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. 2Morrow Digital Therapeutics Platforms Product Portfolio Table 95. 2Morrow Recent Development Table 96. Omada Health Company Information Table 97. Omada Health Business Overview Table 98. Omada Health Digital Therapeutics Platforms Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Omada Health Digital Therapeutics Platforms Product Portfolio Table 100. Omada Health Recent Development Table 101. Click Therapeutics Company Information Table 102. Click Therapeutics Business Overview Table 103. Click Therapeutics Digital Therapeutics Platforms Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Click Therapeutics Digital Therapeutics Platforms Product Portfolio Table 105. Click Therapeutics Recent Development Table 106. Orexo Company Information Table 107. Orexo Business Overview Table 108. Orexo Digital Therapeutics Platforms Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Orexo Digital Therapeutics Platforms Product Portfolio Table 110. Orexo Recent Development Table 111. ResMed Company Information Table 112. ResMed Business Overview Table 113. ResMed Digital Therapeutics Platforms Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. ResMed Digital Therapeutics Platforms Product Portfolio Table 115. ResMed Recent Development Table 116. Virta Health Company Information Table 117. Virta Health Business Overview Table 118. Virta Health Digital Therapeutics Platforms Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Virta Health Digital Therapeutics Platforms Product Portfolio Table 120. Virta Health Recent Development Table 121. Bifourmis Company Information Table 122. Bifourmis Business Overview Table 123. Bifourmis Digital Therapeutics Platforms Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Bifourmis Digital Therapeutics Platforms Product Portfolio Table 125. Bifourmis Recent Development Table 126. SilverCloud (Amwell) Company Information Table 127. SilverCloud (Amwell) Business Overview Table 128. SilverCloud (Amwell) Digital Therapeutics Platforms Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. SilverCloud (Amwell) Digital Therapeutics Platforms Product Portfolio Table 130. SilverCloud (Amwell) Recent Development Table 131. Noom Company Information Table 132. Noom Business Overview Table 133. Noom Digital Therapeutics Platforms Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Noom Digital Therapeutics Platforms Product Portfolio Table 135. Noom Recent Development Table 136. Big Health Company Information Table 137. Big Health Business Overview Table 138. Big Health Digital Therapeutics Platforms Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Big Health Digital Therapeutics Platforms Product Portfolio Table 140. Big Health Recent Development Table 141. Kaia Health Company Information Table 142. Kaia Health Business Overview Table 143. Kaia Health Digital Therapeutics Platforms Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. Kaia Health Digital Therapeutics Platforms Product Portfolio Table 145. Kaia Health Recent Development Table 146. Cognoa Company Information Table 147. Cognoa Business Overview Table 148. Cognoa Digital Therapeutics Platforms Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 149. Cognoa Digital Therapeutics Platforms Product Portfolio Table 150. Cognoa Recent Development Table 151. Headspace Health Company Information Table 152. Headspace Health Business Overview Table 153. Headspace Health Digital Therapeutics Platforms Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 154. Headspace Health Digital Therapeutics Platforms Product Portfolio Table 155. Headspace Health Recent Development Table 156. CureApp Company Information Table 157. CureApp Business Overview Table 158. CureApp Digital Therapeutics Platforms Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 159. CureApp Digital Therapeutics Platforms Product Portfolio Table 160. CureApp Recent Development Table 161. Calm Health Company Information Table 162. Calm Health Business Overview Table 163. Calm Health Digital Therapeutics Platforms Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 164. Calm Health Digital Therapeutics Platforms Product Portfolio Table 165. Calm Health Recent Development Table 166. Riva Health Company Information Table 167. Riva Health Business Overview Table 168. Riva Health Digital Therapeutics Platforms Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 169. Riva Health Digital Therapeutics Platforms Product Portfolio Table 170. Riva Health Recent Development Table 171. Sweetch-Health Company Information Table 172. Sweetch-Health Business Overview Table 173. Sweetch-Health Digital Therapeutics Platforms Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 174. Sweetch-Health Digital Therapeutics Platforms Product Portfolio Table 175. Sweetch-Health Recent Development Table 176. Lark Health Company Information Table 177. Lark Health Business Overview Table 178. Lark Health Digital Therapeutics Platforms Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 179. Lark Health Digital Therapeutics Platforms Product Portfolio Table 180. Lark Health Recent Development Table 181. Vida Health Company Information Table 182. Vida Health Business Overview Table 183. Vida Health Digital Therapeutics Platforms Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 184. Vida Health Digital Therapeutics Platforms Product Portfolio Table 185. Vida Health Recent Development Table 186. Mahana Therapeutics Company Information Table 187. Mahana Therapeutics Business Overview Table 188. Mahana Therapeutics Digital Therapeutics Platforms Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 189. Mahana Therapeutics Digital Therapeutics Platforms Product Portfolio Table 190. Mahana Therapeutics Recent Development Table 191. Blue Note Therapeutics Company Information Table 192. Blue Note Therapeutics Business Overview Table 193. Blue Note Therapeutics Digital Therapeutics Platforms Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 194. Blue Note Therapeutics Digital Therapeutics Platforms Product Portfolio Table 195. Blue Note Therapeutics Recent Development Table 196. Lyra Health Company Information Table 197. Lyra Health Business Overview Table 198. Lyra Health Digital Therapeutics Platforms Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 199. Lyra Health Digital Therapeutics Platforms Product Portfolio Table 200. Lyra Health Recent Development Table 201. Modern Health Company Information Table 202. Modern Health Business Overview Table 203. Modern Health Digital Therapeutics Platforms Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 204. Modern Health Digital Therapeutics Platforms Product Portfolio Table 205. Modern Health Recent Development Table 206. Canary Health Company Information Table 207. Canary Health Business Overview Table 208. Canary Health Digital Therapeutics Platforms Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 209. Canary Health Digital Therapeutics Platforms Product Portfolio Table 210. Canary Health Recent Development Table 211. Virgin Pulse Company Information Table 212. Virgin Pulse Business Overview Table 213. Virgin Pulse Digital Therapeutics Platforms Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 214. Virgin Pulse Digital Therapeutics Platforms Product Portfolio Table 215. Virgin Pulse Recent Development Table 216. Slanhealth Company Information Table 217. Slanhealth Business Overview Table 218. Slanhealth Digital Therapeutics Platforms Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 219. Slanhealth Digital Therapeutics Platforms Product Portfolio Table 220. Slanhealth Recent Development Table 221. Best Covered Company Information Table 222. Best Covered Business Overview Table 223. Best Covered Digital Therapeutics Platforms Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 224. Best Covered Digital Therapeutics Platforms Product Portfolio Table 225. Best Covered Recent Development Table 226. Dami and Xiaomi Company Information Table 227. Dami and Xiaomi Business Overview Table 228. Dami and Xiaomi Digital Therapeutics Platforms Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 229. Dami and Xiaomi Digital Therapeutics Platforms Product Portfolio Table 230. Dami and Xiaomi Recent Development Table 231. WeiMai Company Information Table 232. WeiMai Business Overview Table 233. WeiMai Digital Therapeutics Platforms Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 234. WeiMai Digital Therapeutics Platforms Product Portfolio Table 235. WeiMai Recent Development Table 236. Jianhai Tech Company Information Table 237. Jianhai Tech Business Overview Table 238. Jianhai Tech Digital Therapeutics Platforms Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 239. Jianhai Tech Digital Therapeutics Platforms Product Portfolio Table 240. Jianhai Tech Recent Development Table 241. Research Programs/Design for This Report Table 242. Authors List of This Report Table 243. Secondary Sources Table 244. Primary Sources List of Figures Figure 1. Digital Therapeutics Platforms Product Image Figure 2. Global Digital Therapeutics Platforms Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Digital Therapeutics Platforms Market Size (2021-2032) & (US$ Million) Figure 4. Global Digital Therapeutics Platforms Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Chronic Disease Digital Therapeutics Image Figure 8. Psychiatric Disorders Digital Therapeutics Image Figure 9. Quit Smoking Digital Therapeutics Image Figure 10. Sleep Disorders and Respiratory Diseases Digital Therapeutics Image Figure 11. Others Image Figure 12. Global Digital Therapeutics Platforms Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Digital Therapeutics Platforms Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Digital Therapeutics Platforms Sales Value Share by Type (2021-2032) Figure 15. Enterprise Image Figure 16. Personal Image Figure 17. Global Digital Therapeutics Platforms Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Digital Therapeutics Platforms Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Digital Therapeutics Platforms Sales Value Share by Application (2021-2032) Figure 20. Global Digital Therapeutics Platforms Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Digital Therapeutics Platforms Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Digital Therapeutics Platforms Sales Value (2021-2032) & (US$ Million) Figure 23. North America Digital Therapeutics Platforms Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Digital Therapeutics Platforms Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Digital Therapeutics Platforms Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Digital Therapeutics Platforms Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Digital Therapeutics Platforms Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Digital Therapeutics Platforms Sales Value (2021-2032) & (US$ Million) Figure 29. South America Digital Therapeutics Platforms Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Digital Therapeutics Platforms Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Digital Therapeutics Platforms Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Chronic Disease Digital Therapeutics
  • Psychiatric Disorders Digital Therapeutics
  • Quit Smoking Digital Therapeutics
  • Sleep Disorders and Respiratory Diseases Digital Therapeutics
  • Others
Applications
  • Enterprise
  • Personal
Companies covered
  • Akili Interactive
  • DarioHealth
  • Teladoc Health
  • Voluntis
  • Sidekick Health
  • WellDoc
  • Talkspace
  • CogniFit
  • Tata Elxsi
  • Mahalo Health
  • 2Morrow
  • Omada Health
  • Click Therapeutics
  • Orexo
  • ResMed
  • Virta Health
  • Bifourmis
  • SilverCloud (Amwell)
  • Noom
  • Big Health
  • Kaia Health
  • Cognoa
  • Headspace Health
  • CureApp
  • Calm Health
  • Riva Health
  • Sweetch-Health
  • Lark Health
  • Vida Health
  • Mahana Therapeutics
  • Blue Note Therapeutics
  • Lyra Health
  • Modern Health
  • Canary Health
  • Virgin Pulse
  • Slanhealth
  • Best Covered
  • Dami and Xiaomi
  • WeiMai
  • Jianhai Tech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Digital Therapeutics Platforms Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Digital Therapeutics Platforms Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Digital Therapeutics Platforms Market Dynamics
  1. 2.1 Digital Therapeutics Platforms Industry Trends
  2. 2.2 Digital Therapeutics Platforms Industry Drivers
  3. 2.3 Digital Therapeutics Platforms Industry Opportunities and Challenges
  4. 2.4 Digital Therapeutics Platforms Industry Restraints
3 Digital Therapeutics Platforms Market by Company
  1. 3.1 Global Digital Therapeutics Platforms Company Revenue Ranking in 2025
  2. 3.2 Global Digital Therapeutics Platforms Revenue by Company (2021-2026)
  3. 3.3 Global Digital Therapeutics Platforms Company Ranking (2024-2026)
  4. 3.4 Global Digital Therapeutics Platforms Company Manufacturing Base and Headquarters
  5. 3.5 Global Digital Therapeutics Platforms Company Product Type and Application
  6. 3.6 Global Digital Therapeutics Platforms Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Digital Therapeutics Platforms Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Digital Therapeutics Platforms Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Digital Therapeutics Platforms Market by Type
  1. 4.1 Digital Therapeutics Platforms Type Introduction
  2. 4.1.1 Chronic Disease Digital Therapeutics
  3. 4.1.2 Psychiatric Disorders Digital Therapeutics
  4. 4.1.3 Quit Smoking Digital Therapeutics
  5. 4.1.4 Sleep Disorders and Respiratory Diseases Digital Therapeutics
  6. 4.1.5 Others
  7. 4.2 Global Digital Therapeutics Platforms Sales Value by Type
  8. 4.2.1 Global Digital Therapeutics Platforms Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Digital Therapeutics Platforms Sales Value by Type (2021-2032)
  10. 4.2.3 Global Digital Therapeutics Platforms Sales Value Share by Type (2021-2032)
5 Digital Therapeutics Platforms Market by Application
  1. 5.1 Digital Therapeutics Platforms Application Introduction
  2. 5.1.1 Enterprise
  3. 5.1.2 Personal
  4. 5.2 Global Digital Therapeutics Platforms Sales Value by Application
  5. 5.2.1 Global Digital Therapeutics Platforms Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Digital Therapeutics Platforms Sales Value by Application (2021-2032)
  7. 5.2.3 Global Digital Therapeutics Platforms Sales Value Share by Application (2021-2032)
6 Digital Therapeutics Platforms Regional Value Analysis
  1. 6.1 Global Digital Therapeutics Platforms Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Digital Therapeutics Platforms Sales Value by Region (2021-2032)
  3. 6.2.1 Global Digital Therapeutics Platforms Sales Value by Region: 2021-2026
  4. 6.2.2 Global Digital Therapeutics Platforms Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Digital Therapeutics Platforms Sales Value (2021-2032)
  7. 6.3.2 North America Digital Therapeutics Platforms Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Digital Therapeutics Platforms Sales Value (2021-2032)
  10. 6.4.2 Europe Digital Therapeutics Platforms Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Digital Therapeutics Platforms Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Digital Therapeutics Platforms Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Digital Therapeutics Platforms Sales Value (2021-2032)
  16. 6.6.2 South America Digital Therapeutics Platforms Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Digital Therapeutics Platforms Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Digital Therapeutics Platforms Sales Value Share by Country, 2025 VS 2032
7 Digital Therapeutics Platforms Country-level Value Analysis
  1. 7.1 Global Digital Therapeutics Platforms Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Digital Therapeutics Platforms Sales Value by Country (2021-2032)
  3. 7.2.1 Global Digital Therapeutics Platforms Sales Value by Country (2021-2026)
  4. 7.2.2 Global Digital Therapeutics Platforms Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Digital Therapeutics Platforms Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Digital Therapeutics Platforms Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Digital Therapeutics Platforms Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Akili Interactive
  2. 8.1.1 Akili Interactive Company Information
  3. 8.1.2 Akili Interactive Business Overview
  4. 8.1.3 Akili Interactive Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Akili Interactive Digital Therapeutics Platforms Product Portfolio
  6. 8.1.5 Akili Interactive Recent Developments
  7. 8.2 DarioHealth
  8. 8.2.1 DarioHealth Company Information
  9. 8.2.2 DarioHealth Business Overview
  10. 8.2.3 DarioHealth Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  11. 8.2.4 DarioHealth Digital Therapeutics Platforms Product Portfolio
  12. 8.2.5 DarioHealth Recent Developments
  13. 8.3 Teladoc Health
  14. 8.3.1 Teladoc Health Company Information
  15. 8.3.2 Teladoc Health Business Overview
  16. 8.3.3 Teladoc Health Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Teladoc Health Digital Therapeutics Platforms Product Portfolio
  18. 8.3.5 Teladoc Health Recent Developments
  19. 8.4 Voluntis
  20. 8.4.1 Voluntis Company Information
  21. 8.4.2 Voluntis Business Overview
  22. 8.4.3 Voluntis Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Voluntis Digital Therapeutics Platforms Product Portfolio
  24. 8.4.5 Voluntis Recent Developments
  25. 8.5 Sidekick Health
  26. 8.5.1 Sidekick Health Company Information
  27. 8.5.2 Sidekick Health Business Overview
  28. 8.5.3 Sidekick Health Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sidekick Health Digital Therapeutics Platforms Product Portfolio
  30. 8.5.5 Sidekick Health Recent Developments
  31. 8.6 WellDoc
  32. 8.6.1 WellDoc Company Information
  33. 8.6.2 WellDoc Business Overview
  34. 8.6.3 WellDoc Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  35. 8.6.4 WellDoc Digital Therapeutics Platforms Product Portfolio
  36. 8.6.5 WellDoc Recent Developments
  37. 8.7 Talkspace
  38. 8.7.1 Talkspace Company Information
  39. 8.7.2 Talkspace Business Overview
  40. 8.7.3 Talkspace Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Talkspace Digital Therapeutics Platforms Product Portfolio
  42. 8.7.5 Talkspace Recent Developments
  43. 8.8 CogniFit
  44. 8.8.1 CogniFit Company Information
  45. 8.8.2 CogniFit Business Overview
  46. 8.8.3 CogniFit Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  47. 8.8.4 CogniFit Digital Therapeutics Platforms Product Portfolio
  48. 8.8.5 CogniFit Recent Developments
  49. 8.9 Tata Elxsi
  50. 8.9.1 Tata Elxsi Company Information
  51. 8.9.2 Tata Elxsi Business Overview
  52. 8.9.3 Tata Elxsi Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Tata Elxsi Digital Therapeutics Platforms Product Portfolio
  54. 8.9.5 Tata Elxsi Recent Developments
  55. 8.10 Mahalo Health
  56. 8.10.1 Mahalo Health Company Information
  57. 8.10.2 Mahalo Health Business Overview
  58. 8.10.3 Mahalo Health Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Mahalo Health Digital Therapeutics Platforms Product Portfolio
  60. 8.10.5 Mahalo Health Recent Developments
  61. 8.11 2Morrow
  62. 8.11.1 2Morrow Company Information
  63. 8.11.2 2Morrow Business Overview
  64. 8.11.3 2Morrow Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  65. 8.11.4 2Morrow Digital Therapeutics Platforms Product Portfolio
  66. 8.11.5 2Morrow Recent Developments
  67. 8.12 Omada Health
  68. 8.12.1 Omada Health Company Information
  69. 8.12.2 Omada Health Business Overview
  70. 8.12.3 Omada Health Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Omada Health Digital Therapeutics Platforms Product Portfolio
  72. 8.12.5 Omada Health Recent Developments
  73. 8.13 Click Therapeutics
  74. 8.13.1 Click Therapeutics Company Information
  75. 8.13.2 Click Therapeutics Business Overview
  76. 8.13.3 Click Therapeutics Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Click Therapeutics Digital Therapeutics Platforms Product Portfolio
  78. 8.13.5 Click Therapeutics Recent Developments
  79. 8.14 Orexo
  80. 8.14.1 Orexo Company Information
  81. 8.14.2 Orexo Business Overview
  82. 8.14.3 Orexo Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Orexo Digital Therapeutics Platforms Product Portfolio
  84. 8.14.5 Orexo Recent Developments
  85. 8.15 ResMed
  86. 8.15.1 ResMed Company Information
  87. 8.15.2 ResMed Business Overview
  88. 8.15.3 ResMed Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  89. 8.15.4 ResMed Digital Therapeutics Platforms Product Portfolio
  90. 8.15.5 ResMed Recent Developments
  91. 8.16 Virta Health
  92. 8.16.1 Virta Health Company Information
  93. 8.16.2 Virta Health Business Overview
  94. 8.16.3 Virta Health Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Virta Health Digital Therapeutics Platforms Product Portfolio
  96. 8.16.5 Virta Health Recent Developments
  97. 8.17 Bifourmis
  98. 8.17.1 Bifourmis Company Information
  99. 8.17.2 Bifourmis Business Overview
  100. 8.17.3 Bifourmis Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Bifourmis Digital Therapeutics Platforms Product Portfolio
  102. 8.17.5 Bifourmis Recent Developments
  103. 8.18 SilverCloud (Amwell)
  104. 8.18.1 SilverCloud (Amwell) Company Information
  105. 8.18.2 SilverCloud (Amwell) Business Overview
  106. 8.18.3 SilverCloud (Amwell) Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  107. 8.18.4 SilverCloud (Amwell) Digital Therapeutics Platforms Product Portfolio
  108. 8.18.5 SilverCloud (Amwell) Recent Developments
  109. 8.19 Noom
  110. 8.19.1 Noom Company Information
  111. 8.19.2 Noom Business Overview
  112. 8.19.3 Noom Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Noom Digital Therapeutics Platforms Product Portfolio
  114. 8.19.5 Noom Recent Developments
  115. 8.20 Big Health
  116. 8.20.1 Big Health Company Information
  117. 8.20.2 Big Health Business Overview
  118. 8.20.3 Big Health Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Big Health Digital Therapeutics Platforms Product Portfolio
  120. 8.20.5 Big Health Recent Developments
  121. 8.21 Kaia Health
  122. 8.21.1 Kaia Health Company Information
  123. 8.21.2 Kaia Health Business Overview
  124. 8.21.3 Kaia Health Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Kaia Health Digital Therapeutics Platforms Product Portfolio
  126. 8.21.5 Kaia Health Recent Developments
  127. 8.22 Cognoa
  128. 8.22.1 Cognoa Company Information
  129. 8.22.2 Cognoa Business Overview
  130. 8.22.3 Cognoa Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Cognoa Digital Therapeutics Platforms Product Portfolio
  132. 8.22.5 Cognoa Recent Developments
  133. 8.23 Headspace Health
  134. 8.23.1 Headspace Health Company Information
  135. 8.23.2 Headspace Health Business Overview
  136. 8.23.3 Headspace Health Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Headspace Health Digital Therapeutics Platforms Product Portfolio
  138. 8.23.5 Headspace Health Recent Developments
  139. 8.24 CureApp
  140. 8.24.1 CureApp Company Information
  141. 8.24.2 CureApp Business Overview
  142. 8.24.3 CureApp Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  143. 8.24.4 CureApp Digital Therapeutics Platforms Product Portfolio
  144. 8.24.5 CureApp Recent Developments
  145. 8.25 Calm Health
  146. 8.25.1 Calm Health Company Information
  147. 8.25.2 Calm Health Business Overview
  148. 8.25.3 Calm Health Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Calm Health Digital Therapeutics Platforms Product Portfolio
  150. 8.25.5 Calm Health Recent Developments
  151. 8.26 Riva Health
  152. 8.26.1 Riva Health Company Information
  153. 8.26.2 Riva Health Business Overview
  154. 8.26.3 Riva Health Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  155. 8.26.4 Riva Health Digital Therapeutics Platforms Product Portfolio
  156. 8.26.5 Riva Health Recent Developments
  157. 8.27 Sweetch-Health
  158. 8.27.1 Sweetch-Health Company Information
  159. 8.27.2 Sweetch-Health Business Overview
  160. 8.27.3 Sweetch-Health Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  161. 8.27.4 Sweetch-Health Digital Therapeutics Platforms Product Portfolio
  162. 8.27.5 Sweetch-Health Recent Developments
  163. 8.28 Lark Health
  164. 8.28.1 Lark Health Company Information
  165. 8.28.2 Lark Health Business Overview
  166. 8.28.3 Lark Health Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  167. 8.28.4 Lark Health Digital Therapeutics Platforms Product Portfolio
  168. 8.28.5 Lark Health Recent Developments
  169. 8.29 Vida Health
  170. 8.29.1 Vida Health Company Information
  171. 8.29.2 Vida Health Business Overview
  172. 8.29.3 Vida Health Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  173. 8.29.4 Vida Health Digital Therapeutics Platforms Product Portfolio
  174. 8.29.5 Vida Health Recent Developments
  175. 8.30 Mahana Therapeutics
  176. 8.30.1 Mahana Therapeutics Company Information
  177. 8.30.2 Mahana Therapeutics Business Overview
  178. 8.30.3 Mahana Therapeutics Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  179. 8.30.4 Mahana Therapeutics Digital Therapeutics Platforms Product Portfolio
  180. 8.30.5 Mahana Therapeutics Recent Developments
  181. 8.31 Blue Note Therapeutics
  182. 8.31.1 Blue Note Therapeutics Company Information
  183. 8.31.2 Blue Note Therapeutics Business Overview
  184. 8.31.3 Blue Note Therapeutics Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  185. 8.31.4 Blue Note Therapeutics Digital Therapeutics Platforms Product Portfolio
  186. 8.31.5 Blue Note Therapeutics Recent Developments
  187. 8.32 Lyra Health
  188. 8.32.1 Lyra Health Company Information
  189. 8.32.2 Lyra Health Business Overview
  190. 8.32.3 Lyra Health Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  191. 8.32.4 Lyra Health Digital Therapeutics Platforms Product Portfolio
  192. 8.32.5 Lyra Health Recent Developments
  193. 8.33 Modern Health
  194. 8.33.1 Modern Health Company Information
  195. 8.33.2 Modern Health Business Overview
  196. 8.33.3 Modern Health Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  197. 8.33.4 Modern Health Digital Therapeutics Platforms Product Portfolio
  198. 8.33.5 Modern Health Recent Developments
  199. 8.34 Canary Health
  200. 8.34.1 Canary Health Company Information
  201. 8.34.2 Canary Health Business Overview
  202. 8.34.3 Canary Health Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  203. 8.34.4 Canary Health Digital Therapeutics Platforms Product Portfolio
  204. 8.34.5 Canary Health Recent Developments
  205. 8.35 Virgin Pulse
  206. 8.35.1 Virgin Pulse Company Information
  207. 8.35.2 Virgin Pulse Business Overview
  208. 8.35.3 Virgin Pulse Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  209. 8.35.4 Virgin Pulse Digital Therapeutics Platforms Product Portfolio
  210. 8.35.5 Virgin Pulse Recent Developments
  211. 8.36 Slanhealth
  212. 8.36.1 Slanhealth Company Information
  213. 8.36.2 Slanhealth Business Overview
  214. 8.36.3 Slanhealth Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  215. 8.36.4 Slanhealth Digital Therapeutics Platforms Product Portfolio
  216. 8.36.5 Slanhealth Recent Developments
  217. 8.37 Best Covered
  218. 8.37.1 Best Covered Company Information
  219. 8.37.2 Best Covered Business Overview
  220. 8.37.3 Best Covered Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  221. 8.37.4 Best Covered Digital Therapeutics Platforms Product Portfolio
  222. 8.37.5 Best Covered Recent Developments
  223. 8.38 Dami and Xiaomi
  224. 8.38.1 Dami and Xiaomi Company Information
  225. 8.38.2 Dami and Xiaomi Business Overview
  226. 8.38.3 Dami and Xiaomi Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  227. 8.38.4 Dami and Xiaomi Digital Therapeutics Platforms Product Portfolio
  228. 8.38.5 Dami and Xiaomi Recent Developments
  229. 8.39 WeiMai
  230. 8.39.1 WeiMai Company Information
  231. 8.39.2 WeiMai Business Overview
  232. 8.39.3 WeiMai Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  233. 8.39.4 WeiMai Digital Therapeutics Platforms Product Portfolio
  234. 8.39.5 WeiMai Recent Developments
  235. 8.40 Jianhai Tech
  236. 8.40.1 Jianhai Tech Company Information
  237. 8.40.2 Jianhai Tech Business Overview
  238. 8.40.3 Jianhai Tech Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  239. 8.40.4 Jianhai Tech Digital Therapeutics Platforms Product Portfolio
  240. 8.40.5 Jianhai Tech Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst